• Explore /
  • Poster
  • / Phase II trial of consolidation pembrolizumab (pembro) after proton reirradiation (re-RT) for thoracic recurrences of non-small cell lung cancer (NSCLC).

Phase II trial of consolidation pembrolizumab (pembro) after proton reirradiation (re-RT) for thoracic recurrences of non-small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Nikhil Yegya-Raman

University of Pennsylvania, Philadelphia, PA

Nikhil Yegya-Raman , Abigail T. Berman , Christine Agnes Ciunci , Xingmei Wang , Cole Friedes , Michelle Iocolano , Ching Lai , William P. Levin , Keith A. Cengel , Roger B. Cohen , Charu Aggarwal , Melina Elpi Marmarelis , Aditi Puri Singh , Lova Sun , John Peter Plastaras , Corey J. Langer , Charles B. Simone II, Steven J Feigenberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03087760

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 8552)

DOI

10.1200/JCO.2023.41.16_suppl.8552

Abstract #

8552

Poster Bd #

179

Abstract Disclosures

Similar Posters

First Author: Christophe Le Tourneau

First Author: Giuseppe Lo Russo

First Author: Mario Javier Pineda

First Author: Assuntina Gesualda Sacco